# A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma

> **NCT00062933** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 40 (—)

## Conditions studied

- Melanoma

## Interventions

- **PROCEDURE:** Laparotomy

## Key facts

- **NCT ID:** NCT00062933
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2007-09
- **Final completion:** 2008-03
- **Target enrollment:** 40 (—)
- **Last updated:** 2012-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00062933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00062933, "A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00062933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*